
Group leader @KingsCollegeLon // Interest in #CLL & #Lymphoma immunology, #TumorMicroenvironment, #Immunosuppression and pre-clinical translation.
London, UK
Joined July 2020
- Tweets47
- Following206
- Followers281
- Likes223
Dr Alan G Ramsay retweeted
📢Our new paper is out in @ScienceTM 📢
Diabetic retinopathy (DR) is a leading cause of blindness. Patients show vascular changes in their retinas long before vision starts to deteriorate.
What triggers these early defects? Could targeting them prevent vision loss? 🧵
Dr Alan G Ramsay retweeted
12 covers have been selected for the 9th Annual Blood Cover Art Contest. Vote now! Voting closes February 7, 2025 and the winner will be announced February 13, 2025. ow.ly/pyBB50UFKm2
Dr Alan G Ramsay retweeted
🚨New paper alert!🚨@LabWhiteford and I are excited to share our latest research published in @BrJPharmacol describing the development and pre-clinical testing 🧪of a novel peptide for neovascular (or wet) age-related macular degeneration (nvAMD).
(Quick 🧵below)
Dr Alan G Ramsay retweeted
Our review article on the tumor microenvironment in B-cell lymphoma, part of a series collection, is available in Blood. Full access link
authors.elsevier.com/a/1ioEY…
@BloodJournal
Dr Alan G Ramsay retweeted
If you are keen to work as a POSTDOC with us in London on translational cancer research and tumour microenvironment signalling- please apply....5 days left!! ucl.ac.uk/work-at-ucl/search…
Dr Alan G Ramsay retweeted
Discovering the fibroblastic reticular cell in the immune tumor microenvironment in lymphoma: buff.ly/3NypGS0
Adam Yuh Lin & @ligordon highlight FRCs as a potential target to optimize immunotherapy for treatment of lymphoma; #Commentary
Related: buff.ly/43d2z5p
Dr Alan G Ramsay retweeted
Fibroblasts suppress T cells in diffuse large B cell lymphoma: buff.ly/43d2z5p
@RamsayLab @KingsCollegeLon
#Immunology #Oncology
Dr Alan G Ramsay retweeted
Targeting the tumour environment could improve immunotherapy responses for lymphoma patients
Research from @RamsayLab shows how this cancer reprogrammes cells key to our immune system
Read more below ⤵️ #lymphoma #immunesystem
kcl.ac.uk/news/targeting-the…
Dr Alan G Ramsay retweeted
Very proud of my first TEM image 😍 - well, I only contributed the sample and the coloring skills, the image was taken by TEM master @BioBurgoyne.
Retinal capillary: Pericyte in green, EC in blue, BM in yellow and RBC in red.
#SciComm #eye #microscopy #STEM
#DiabeticRetinopathy
Dr Alan G Ramsay retweeted
Big shoutout to Despoina Papazoglou from @RamsayLab.
@UkCll forum travel grant winner, presenting elegant work of in vitro bi-specific therapy in #CLL successfully engaging T-cell response.
Dr Alan G Ramsay retweeted
Our new review on the multifaceted roles of #LRG1 as a vasculopathic, pro-fibrotic and immunomodulatory factor in #eye disease.
Could it be a potential alternative target to #VEGF?
👉rdcu.be/cELVO
#openaccess from @Eye_Journal
#Ophthalmology #retina #retinopathy
Dr Alan G Ramsay retweeted
Register and Attend in person our next Clinical Sciences Day - Friday 8th Oct - London, Cavendish Conference Centre, W1G 9DT OR log-in to join virtually! Guest talks from Prof Carsten Niemann, Prof Arnon Kater, and Dr William Wierda (CAR T cells in CLL)..
collaborativeconferences.co.…
Dr Alan G Ramsay retweeted
Brilliant work from Alan Ramsey from @KingsCollegeLon on the cooperative anti-tumour activity of avadomide and PDL-1/PD-1 inhibition for #CLL both in vitro and in vivo.
Dr Alan G Ramsay retweeted
Syndecan-4 is a checkpoint for VEGFA-driven VE-Cadherin internalization - implications for pathological angiogenesis and hyperpermeability. @GDR_tweets @TeroJrvinen3 @Hannele25771568 @LabWhiteford ow.ly/2zGM50DPmDC
Dr Alan G Ramsay retweeted
Here is the programme for the UK CLL Forum Annual Scientific Day on 10th March.
Registration here!
collaborativeconferences.co.…
#CLL #CLLForum
















